Tianyou Zhan, MD

National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC
Beijing, Beijing

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 2190 - Optimized Hippo-Avoidance Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer Treated with First-Line Chemoradiotherapy

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET

• 2191 - Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET

• 2192 - Conditional Survival and Hazard Rates of Patients with LS-SCLC Underwent IMRT in the First-Line Chemoradiotherapy Era: Influence of Prognostics Factors over Time

  Sunday, September 29, 2024
  2:45 PM – 4:15 PM ET

• 194 - Simultaneous Integrated Boost vs. Conventional Radiotherapy for Patients with Limited-Stage Small Cell Lung Cancer: A Randomized, Non-Inferiority, Open-Label, Phase 3 Trial

  Monday, September 30, 2024
  11:45 AM – 11:55 AM ET